Physician profile
Benjamin E Niver
NPI 1043657067
$5,354.65
in general payments reported to CMS, 2019-2025
44 companies · $736 in 2025
The $736 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $666 · 2021: $714 · 2022: $910 · 2023: $754 · 2024: $1,285 · 2025: $736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,446 · Travel and Lodging: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,446.06 |
| Travel and Lodging | $328.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $708.12 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Endo Pharmaceuticals INC. | $486.61 | 2019-2023 | Edex, Xiaflex, Aveed |
| Teleflex LLC | $454.60 | 2023-2025 | Urolift |
| Abbvie INC. | $445.17 | 2020-2025 | |
| Astellas Pharma US INC | $403.52 | 2019-2024 | Myrbetriq, Xtandi |
| Boston Scientific Corporation | $363.44 | 2022-2025 | Ams 700, Lithovue |
| Neotract INC. | $259.47 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $173.29 | 2021-2023 | |
| Axonics, INC. | $159.28 | 2020-2022 | |
| Coloplast Corp | $137.49 | 2020-2022 | |
| Ferring Pharmaceuticals INC. | $129.41 | 2019-2025 | Adstiladrin |
| Srs Medical Systems, INC. | $118.48 | 2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Janssen Biotech, INC. | $106.54 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $97.45 | 2021-2024 | Keytruda |
| Immunitybio, INC. | $94.11 | 2024-2025 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $91.19 | 2020-2023 | Jelmyto |
| Urovant Sciences INC | $85.38 | 2021-2022 | |
| Myovant Sciences INC. | $83.55 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $82.97 | 2020-2025 | Provenge |
| Pfizer INC. | $75.64 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $70.08 | 2023-2025 | Orgovyx, Gemtesa |
| Calyxo, INC. | $69.18 | 2022-2024 | Cvac Aspiration System |
| Olympus America INC. | $62.26 | 2023-2025 | Itind System |
| Hollister Incorporated | $61.45 | 2022-2023 | Vapro, Onli |
| Sun Pharmaceutical Industries INC. | $54.65 | 2021-2023 | Yonsa |
| Accord Healthcare, INC. | $51.82 | 2023-2024 | |
| Amgen INC. | $46.50 | 2020-2023 | Prolia |
| Clarus Therapeutics INC. | $44.91 | 2021 | |
| Blue Earth Diagnostics | $42.05 | 2021 | |
| Genzyme Corporation | $38.20 | 2020-2022 | |
| Antares Pharma, INC. | $36.13 | 2020-2021 | |
| Progenics Pharmaceuticals, INC. | $27.64 | 2022-2023 | Pylarify |
| Civco Medical Instruments | $27.50 | 2025 | |
| Endo USA, INC. | $24.75 | 2025 | Aveed, Xiaflex |
| Conmed Corporation | $16.97 | 2023 | Airseal |
| Verity Pharmaceuticals INC. | $16.74 | 2025 | Tlando |
| Tolmar, INC. | $15.95 | 2024 | |
| Karl Storz Endoscopy-America | $14.82 | 2024 | |
| Acerus Pharmaceuticals Corporation | $13.79 | 2020 | |
| Cook Medical LLC | $13.65 | 2025 | Litho 150 |
| Tolmar Pharmaceuticals, INC. | $13.61 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $12.48 | 2020 | |
| Allergan, INC. | $11.97 | 2020 | |
| Valencia Technologies Corporation | $11.84 | 2025 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Niver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.